1. Home
  2. AKYA
  3. AKYA News

Latest Akoya BioSciences Inc. (AKYA) News on April 1, 2025

AKYA

MT Newswires

7 days ago

Akoya Biosciences Shares Fall After Downgrade From Stephens

AKYA

MT Newswires

7 days ago

Stephens Downgrades Akoya Biosciences to Equalweight From Overweight, Price Target is $1.80

AKYA

Thomson Reuters StreetEvents

14 days ago

Q4 2024 Quanterix Corp Earnings Call

Quanterix Corp (QTRX) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amid Market Challenges
AKYA

GuruFocus.com

15 days ago

Quanterix Corp (QTRX) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amid Market Challenges

Akoya Biosciences (AKYA) Reports Q4 Loss, Lags Revenue Estimates
AKYA

Zacks

15 days ago

Akoya Biosciences (AKYA) Reports Q4 Loss, Lags Revenue Estimates

AKYA

Associated Press Finance

15 days ago

Akoya: Q4 Earnings Snapshot

Akoya Reports Fourth Quarter of 2024 and Full Year Financial Results
AKYA

GlobeNewswire

15 days ago

Akoya Reports Fourth Quarter of 2024 and Full Year Financial Results

AKYA

MT Newswires

21 days ago

Quanterix Shareholder Opposes Proposed Akoya Biosciences Merger

AKYA

MT Newswires

a month ago

Piper Sandler Downgrades Akoya Biosciences to Neutral From Overweight, Adjusts Price Target to $2.40 From $3

Akoya Biosciences unveils strategic product roadmap
AKYA

TipRanks

2 months ago

Akoya Biosciences unveils strategic product roadmap

Akoya Biosciences Unveils Strategic Product Roadmap, Powered by the New IO60 and Upcoming Neurobiology Panels
AKYA

GlobeNewswire

2 months ago

Akoya Biosciences Unveils Strategic Product Roadmap, Powered by the New IO60 and Upcoming Neurobiology Panels

AKYA

MT Newswires

3 months ago

Canaccord Genuity Downgrades Akoya Biosciences to Hold From Buy, $3.50 Price Target

AKYA

MT Newswires

3 months ago

Top Premarket Gainers

AKYA

MT Newswires

3 months ago

Quanterix Agrees to Acquire Akoya Biosciences in All-Stock Deal

AKYA

Business Wire

3 months ago

Quanterix to Acquire Akoya Biosciences, Creating the First Integrated Solution for Ultra-Sensitive Detection of Blood- and Tissue-Based Protein Biomarkers

AKYA

MT Newswires

4 months ago

Akoya Biosciences Secures Exclusive License for NeraCare's Immunoprint Test

Akoya Biosciences and NeraCare Enter into an Exclusive Global License Agreement for the Development and Commercialization of the Immunoprint Test for Early-Stage Melanoma Patient Treatment Decisions
AKYA

GlobeNewswire

4 months ago

Akoya Biosciences and NeraCare Enter into an Exclusive Global License Agreement for the Development and Commercialization of the Immunoprint Test for Early-Stage Melanoma Patient Treatment Decisions

Nature Methods Names Spatial Proteomics "Method of the Year 2024" — Akoya Biosciences Celebrates Industry Milestone
AKYA

GlobeNewswire

4 months ago

Nature Methods Names Spatial Proteomics "Method of the Year 2024" — Akoya Biosciences Celebrates Industry Milestone

Time To Worry? Analysts Just Downgraded Their Akoya Biosciences, Inc. (NASDAQ:AKYA) Outlook
AKYA

Simply Wall St.

4 months ago

Time To Worry? Analysts Just Downgraded Their Akoya Biosciences, Inc. (NASDAQ:AKYA) Outlook

Akoya Biosciences Third Quarter 2024 Earnings: Misses Expectations
AKYA

Simply Wall St.

5 months ago

Akoya Biosciences Third Quarter 2024 Earnings: Misses Expectations

AKYA

GuruFocus.com

5 months ago

Akoya Biosciences Inc (AKYA) Q3 2024 Earnings Call Highlights: Navigating Revenue Challenges ...

Akoya Biosciences (AKYA) Reports Q3 Loss, Lags Revenue Estimates
AKYA

Zacks

5 months ago

Akoya Biosciences (AKYA) Reports Q3 Loss, Lags Revenue Estimates

AKYA

Associated Press Finance

5 months ago

Akoya: Q3 Earnings Snapshot

Akoya Biosciences Reports Third Quarter 2024 Financial Results
AKYA

GlobeNewswire

5 months ago

Akoya Biosciences Reports Third Quarter 2024 Financial Results

Akoya Biosciences Inc (AKYA) Q3 2024 Earnings Report Preview: What To Look For
AKYA

GuruFocus.com

5 months ago

Akoya Biosciences Inc (AKYA) Q3 2024 Earnings Report Preview: What To Look For

Akoya Biosciences Unveils a New Era in Spatial Content Innovation with the PhenoCode™ Discovery IO60 and Mouse FFPE IO Panel
AKYA

GlobeNewswire

5 months ago

Akoya Biosciences Unveils a New Era in Spatial Content Innovation with the PhenoCode™ Discovery IO60 and Mouse FFPE IO Panel

Akoya Bioscience to Report Third Quarter 2024 Financial Results on November 14, 2024
AKYA

GlobeNewswire

5 months ago

Akoya Bioscience to Report Third Quarter 2024 Financial Results on November 14, 2024

AKYA

MT Newswires

6 months ago

Akoya Biosciences Spatial Proteomics Platform to be Used in Cancer Immunotherapy Consortium

Akoya’s Leading Spatial Proteomics Platforms Selected for Use by Ground-Breaking UK-Based MANIFEST Consortium to Revolutionize Cancer Immunotherapy
AKYA

GlobeNewswire

6 months ago

Akoya’s Leading Spatial Proteomics Platforms Selected for Use by Ground-Breaking UK-Based MANIFEST Consortium to Revolutionize Cancer Immunotherapy

AKYA

MT Newswires

6 months ago

Akoya Biosciences Appoints Scott Mendel as Chairman

Akoya Biosciences Announces Scott Mendel as Chairman of the Board of Directors
AKYA

GlobeNewswire

6 months ago

Akoya Biosciences Announces Scott Mendel as Chairman of the Board of Directors

Akoya Biosciences Second Quarter 2024 Earnings: Revenues Disappoint
AKYA

Simply Wall St.

8 months ago

Akoya Biosciences Second Quarter 2024 Earnings: Revenues Disappoint

AKYA

MT Newswires

8 months ago

Morgan Stanley Downgrades Akoya Biosciences to Equalweight From Overweight, Adjusts PT to $3 From $4

AKYA

MT Newswires

8 months ago

BTIG Research Downgrades Akoya Biosciences to Neutral From Buy

AKYA

MT Newswires

8 months ago

JPMorgan Downgrades Akoya Biosciences to Neutral From Overweight

Akoya Biosciences (AKYA) Reports Q2 Loss, Misses Revenue Estimates
AKYA

Zacks

8 months ago

Akoya Biosciences (AKYA) Reports Q2 Loss, Misses Revenue Estimates

AKYA

Associated Press Finance

8 months ago

Akoya: Q2 Earnings Snapshot

Akoya Biosciences Reports Second Quarter 2024 Financial Results
AKYA

GlobeNewswire

8 months ago

Akoya Biosciences Reports Second Quarter 2024 Financial Results

Akoya Biosciences to Report Second Quarter 2024 Financial Results on August 5, 2024, and Participate at Two Upcoming Investor Conferences
AKYA

GlobeNewswire

9 months ago

Akoya Biosciences to Report Second Quarter 2024 Financial Results on August 5, 2024, and Participate at Two Upcoming Investor Conferences

While institutions own 21% of Akoya Biosciences, Inc. (NASDAQ:AKYA), private equity firms are its largest shareholders with 49% ownership
AKYA

Simply Wall St.

9 months ago

While institutions own 21% of Akoya Biosciences, Inc. (NASDAQ:AKYA), private equity firms are its largest shareholders with 49% ownership

A Data-Driven Analysis of Netflix's Streaming Dominance and Future Outlook
AKYA

GuruFocus.com

10 months ago

A Data-Driven Analysis of Netflix's Streaming Dominance and Future Outlook

AKYA

Energy Global

10 months ago

ANDRITZ to equip new Silvan hydropower plant in TĂĽrkiye

Supreme Court Justice Alito talks polarization, his wife talks revenge in secret recordings
AKYA

USA TODAY

10 months ago

Supreme Court Justice Alito talks polarization, his wife talks revenge in secret recordings

Indra Energy Drives Sustainability Focus through the Penguins Pledge with the Pittsburgh Penguins
AKYA

Business Wire

10 months ago

Indra Energy Drives Sustainability Focus through the Penguins Pledge with the Pittsburgh Penguins

Pacer ETFs Rings in its 9th Anniversary as Firm nears $50 Billion in Assets Under Management
AKYA

Business Wire

10 months ago

Pacer ETFs Rings in its 9th Anniversary as Firm nears $50 Billion in Assets Under Management

SEALSQ to Launch Two New Quantum Resistant Chips
AKYA

GlobeNewswire

10 months ago

SEALSQ to Launch Two New Quantum Resistant Chips

Shrinking Fed rate cut expectations to keep US Treasury yields elevated: Reuters poll
AKYA

Reuters

10 months ago

Shrinking Fed rate cut expectations to keep US Treasury yields elevated: Reuters poll

Global Upstream Bioprocessing Market Analysis Report 2024-2030: A $59.24 Billion Market by 2030, Registering a CAGR of 14.3% from 2024 to 2030
AKYA

GlobeNewswire

10 months ago

Global Upstream Bioprocessing Market Analysis Report 2024-2030: A $59.24 Billion Market by 2030, Registering a CAGR of 14.3% from 2024 to 2030

AKYA

MT Newswires

10 months ago

Morgan Stanley Cuts Akoya Biosciences Price Target to $4 From $8, Maintains Overweight Rating

We Think Some Shareholders May Hesitate To Increase Akoya Biosciences, Inc.'s (NASDAQ:AKYA) CEO Compensation
AKYA

Simply Wall St.

10 months ago

We Think Some Shareholders May Hesitate To Increase Akoya Biosciences, Inc.'s (NASDAQ:AKYA) CEO Compensation

AKYA

MT Newswires

a year ago

Piper Sandler Cuts Akoya Biosciences Price Target to $6 From $8, Maintains Overweight Rating

AKYA

MT Newswires

a year ago

Top Midday Decliners

AKYA

GuruFocus.com

a year ago

Akoya Biosciences Inc (AKYA) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges ...

AKYA

MT Newswires

a year ago

Top Premarket Decliners

Akoya Biosciences (AKYA) Reports Q1 Loss, Lags Revenue Estimates
AKYA

Zacks

a year ago

Akoya Biosciences (AKYA) Reports Q1 Loss, Lags Revenue Estimates

AKYA

Associated Press Finance

a year ago

Akoya: Q1 Earnings Snapshot

Akoya Biosciences Reports First Quarter 2024 Financial Results
AKYA

GlobeNewswire

a year ago

Akoya Biosciences Reports First Quarter 2024 Financial Results

Akoya Biosciences and NeraCare Enter into an Exclusive Agreement to Enable Personalized Therapy Selection for Early-Stage Melanoma Patients
AKYA

GlobeNewswire

a year ago

Akoya Biosciences and NeraCare Enter into an Exclusive Agreement to Enable Personalized Therapy Selection for Early-Stage Melanoma Patients

Akoya Biosciences (AKYA) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
AKYA

Zacks

a year ago

Akoya Biosciences (AKYA) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Akoya Biosciences Opens Operations and Manufacturing Center of Excellence in Marlborough, Massachusetts
AKYA

GlobeNewswire

a year ago

Akoya Biosciences Opens Operations and Manufacturing Center of Excellence in Marlborough, Massachusetts

Akoya Biosciences and Shanghai KR Pharmtech Announce Chinese Regulatory Agency Premarket Approval for KR-HT5 in China to Support Next Generation Pathology Clinical Workflows
AKYA

GlobeNewswire

a year ago

Akoya Biosciences and Shanghai KR Pharmtech Announce Chinese Regulatory Agency Premarket Approval for KR-HT5 in China to Support Next Generation Pathology Clinical Workflows

Akoya to Report First Quarter 2024 Financial Results on May 13th, 2024
AKYA

GlobeNewswire

a year ago

Akoya to Report First Quarter 2024 Financial Results on May 13th, 2024

Akoya Biosciences Showcases Spatial Biology 2.0 Solutions at AACR Annual Meeting with Case Studies Demonstrating Unprecedented Speed and Scale
AKYA

GlobeNewswire

a year ago

Akoya Biosciences Showcases Spatial Biology 2.0 Solutions at AACR Annual Meeting with Case Studies Demonstrating Unprecedented Speed and Scale

Akoya Biosciences, Inc. (NASDAQ:AKYA) Q4 2023 Earnings Call Transcript
AKYA

Insider Monkey

a year ago

Akoya Biosciences, Inc. (NASDAQ:AKYA) Q4 2023 Earnings Call Transcript

AKYA

Thomson Reuters StreetEvents

a year ago

Q4 2023 Akoya Biosciences Inc Earnings Call

Akoya Biosciences Inc (AKYA) Reports Record Q4 Revenue and Sets Positive 2024 Outlook
AKYA

GuruFocus.com

a year ago

Akoya Biosciences Inc (AKYA) Reports Record Q4 Revenue and Sets Positive 2024 Outlook

Akoya Biosciences (AKYA) Reports Q4 Loss, Tops Revenue Estimates
AKYA

Zacks

a year ago

Akoya Biosciences (AKYA) Reports Q4 Loss, Tops Revenue Estimates

AKYA

Associated Press Finance

a year ago

Akoya: Q4 Earnings Snapshot

Akoya Reports Record Revenue in the Fourth Quarter of 2023 and Provides Full Year 2024 Financial Outlook
AKYA

GlobeNewswire

a year ago

Akoya Reports Record Revenue in the Fourth Quarter of 2023 and Provides Full Year 2024 Financial Outlook

Has Acumen Pharmaceuticals (ABOS) Outpaced Other Medical Stocks This Year?
AKYA

Zacks

a year ago

Has Acumen Pharmaceuticals (ABOS) Outpaced Other Medical Stocks This Year?

Akoya Biosciences Insiders Placed Bullish Bets Worth US$2.11m
AKYA

Simply Wall St.

a year ago

Akoya Biosciences Insiders Placed Bullish Bets Worth US$2.11m

Are Medical Stocks Lagging Aclaris Therapeutics (ACRS) This Year?
AKYA

Zacks

a year ago

Are Medical Stocks Lagging Aclaris Therapeutics (ACRS) This Year?

Akoya to Report Fourth Quarter and Full Year 2023 Financial Results on March 4th, 2024 and Participate at an Upcoming Investor Conference
AKYA

GlobeNewswire

a year ago

Akoya to Report Fourth Quarter and Full Year 2023 Financial Results on March 4th, 2024 and Participate at an Upcoming Investor Conference

Strength Seen in Akoya (AKYA): Can Its 7.4% Jump Turn into More Strength?
AKYA

Zacks

a year ago

Strength Seen in Akoya (AKYA): Can Its 7.4% Jump Turn into More Strength?

Chuck Royce Reduces Stake in Lincoln Educational Services Corp
AKYA

GuruFocus.com

a year ago

Chuck Royce Reduces Stake in Lincoln Educational Services Corp

Bristol Myers' (BMY) sBLAs for Breyanzi Get FDA Priority Tag
AKYA

Zacks

a year ago

Bristol Myers' (BMY) sBLAs for Breyanzi Get FDA Priority Tag

NexPoint Real Estate Finance Announces 2023 Dividend Income Tax Treatment
AKYA

PR Newswire

a year ago

NexPoint Real Estate Finance Announces 2023 Dividend Income Tax Treatment

Alerus Financial Corporation (NASDAQ:ALRS) Q4 2023 Earnings Call Transcript
AKYA

Insider Monkey

a year ago

Alerus Financial Corporation (NASDAQ:ALRS) Q4 2023 Earnings Call Transcript

Is Abbott Laboratories (ABT) Stock Outpacing Its Medical Peers This Year?
AKYA

Zacks

a year ago

Is Abbott Laboratories (ABT) Stock Outpacing Its Medical Peers This Year?

Should Value Investors Buy Brinker International (EAT) Stock?
AKYA

Zacks

a year ago

Should Value Investors Buy Brinker International (EAT) Stock?

Univest Financial Corp (UVSP) Reports Mixed Results for Q4 and Full Year 2023
AKYA

GuruFocus.com

a year ago

Univest Financial Corp (UVSP) Reports Mixed Results for Q4 and Full Year 2023

AKYA

Associated Press Finance

a year ago

Hanmi Financial: Q4 Earnings Snapshot

AKYA

GlobeNewswire

a year ago

Diamond Equity Research to Host Spotlight Emerging Growth Invitational Virtual Investor Conference on January 23, 2024

Akoya Biosciences’ Technology Enables Queensland Spatial Biology Centre to Revolutionize the Diagnosis and Treatment of Cancer and Other Diseases
AKYA

GlobeNewswire

a year ago

Akoya Biosciences’ Technology Enables Queensland Spatial Biology Centre to Revolutionize the Diagnosis and Treatment of Cancer and Other Diseases

Sweetgreen (SG) Expands Domestic Footprint With New Location
AKYA

Zacks

a year ago

Sweetgreen (SG) Expands Domestic Footprint With New Location

Investors in Diamond Hill Investment Group (NASDAQ:DHIL) have unfortunately lost 11% over the last year
AKYA

Simply Wall St.

a year ago

Investors in Diamond Hill Investment Group (NASDAQ:DHIL) have unfortunately lost 11% over the last year

Invesco Municipal Trust's Dividend Analysis
AKYA

GuruFocus.com

a year ago

Invesco Municipal Trust's Dividend Analysis

Akoya Biosciences, Inc.'s (NASDAQ:AKYA) market cap touched US$254m last week, benefiting both private equity firms who own 48% as well as institutions
AKYA

Simply Wall St.

a year ago

Akoya Biosciences, Inc.'s (NASDAQ:AKYA) market cap touched US$254m last week, benefiting both private equity firms who own 48% as well as institutions

Are Medical Stocks Lagging Cigna Group (CI) This Year?
AKYA

Zacks

a year ago

Are Medical Stocks Lagging Cigna Group (CI) This Year?

Akoya Biosciences Announces that Garry Nolan, Ph.D., James Allison, Ph.D., and Padmanee Sharma, M.D., Ph.D., Join Newly Created Scientific Advisory Board
AKYA

GlobeNewswire

a year ago

Akoya Biosciences Announces that Garry Nolan, Ph.D., James Allison, Ph.D., and Padmanee Sharma, M.D., Ph.D., Join Newly Created Scientific Advisory Board

Eos Energy Enterprises and TETRA Technologies, Inc. Extend Partnership, Expanding Electrolyte Production Capacity
AKYA

GlobeNewswire

a year ago

Eos Energy Enterprises and TETRA Technologies, Inc. Extend Partnership, Expanding Electrolyte Production Capacity

Best Momentum Stocks to Buy for January 8th
AKYA

Zacks

a year ago

Best Momentum Stocks to Buy for January 8th

5 Small-Cap Stocks to Play the January Effect
AKYA

Zacks

a year ago

5 Small-Cap Stocks to Play the January Effect

Investors in Seritage Growth Properties (NYSE:SRG) have unfortunately lost 74% over the last five years
AKYA

Simply Wall St.

a year ago

Investors in Seritage Growth Properties (NYSE:SRG) have unfortunately lost 74% over the last five years

MESA LABS DECLARES QUARTERLY DIVIDEND
AKYA

GlobeNewswire

a year ago

MESA LABS DECLARES QUARTERLY DIVIDEND

atai Life Sciences Announces Positive Topline Results from Single Ascending Dose Phase 1 Study with EMP-01 (R-MDMA)
AKYA

GlobeNewswire

a year ago

atai Life Sciences Announces Positive Topline Results from Single Ascending Dose Phase 1 Study with EMP-01 (R-MDMA)

Carriage Services, Inc.'s (NYSE:CSV) Intrinsic Value Is Potentially 48% Above Its Share Price
AKYA

Simply Wall St.

a year ago

Carriage Services, Inc.'s (NYSE:CSV) Intrinsic Value Is Potentially 48% Above Its Share Price

FARO Successfully Completes SOC 2 Type II Audit
AKYA

PR Newswire

a year ago

FARO Successfully Completes SOC 2 Type II Audit

AKYA

Reuters

a year ago

UPDATE 3-Canadian logistics firm TFI International to buy Daseke in $1.1 bln deal

Should You Investigate The Shyft Group, Inc. (NASDAQ:SHYF) At US$12.76?
AKYA

Simply Wall St.

a year ago

Should You Investigate The Shyft Group, Inc. (NASDAQ:SHYF) At US$12.76?

Share on Social Networks: